Dergiler / Turkish Thoracic Journal / 2021 / Cilt: 22 - Sayı: 3

Esophageal Dilatation as a Predictor of Systemic Sclerosis in Patients with Interstitial Lung Disease

Sayfa
231–236
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The optimal calculated cut-off value to differentiate SSc from other ILDs was 18.5 mm (sensitivity andspecificity of 70 and 90%, respectively; area under the curve 0.819), measured 1 cm above the diaphragmatic hiatus.CONCLUSION: HRCT may have a discriminative role in the presence of both ILD and esophageal dilatation for the diagnosis of SSc.Our results suggest that a cut-off value for the esophageal diameter of 18.5 mm might propose the diagnosis of SSc with reasonableconfidence

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:To determine the predictive value of esophageal dilatation as observed in high-resolution computed tomography (HRCT) forthe diagnosis of systemic sclerosis (SSc) in patients with interstitial lung disease (ILD).METHODS: Our sample consisted of patients diagnosed with SSc and proven interstitial lung involvement with available HRCT exams(n = 20).
📊
Temel Bulgular & Veri:Individuals with other forms of rheumatic ILD were included as a control group (n = 20).
💡
Sonuç & Katkı:The optimal calculated cut-off value to differentiate SSc from other ILDs was 18.5 mm (sensitivity andspecificity of 70 and 90%, respectively; area under the curve 0.819), measured 1 cm above the diaphragmatic hiatus.CONCLUSION: HRCT may have a discriminative role in the presence of both ILD and esophageal dilatation for the diagnosis of SSc.Our results suggest that a cut-off value for the esophageal diameter of 18.5 mm might propose the diagnosis of SSc with reasonableconfidence
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

To determine the predictive value of esophageal dilatation as observed in high-resolution computed tomography (HRCT) forthe diagnosis of systemic sclerosis (SSc) in patients with interstitial lung disease (ILD).METHODS: Our sample consisted of patients diagnosed with SSc and proven interstitial lung involvement with available HRCT exams(n = 20). Individuals with other forms of rheumatic ILD were included as a control group (n = 20). Two blinded radiologists independently reviewed the images for the presence of esophageal dilatation, measured at 3 different levels. Interobserver agreement was testedwith Lin’s concordance correlation coefficient (CCC). Independent t-test was used to compare maximum esophageal diameters betweengroups. Friedman's test was used to evaluate differences between the 3-level measurements. Receiver operating characteristic analysiswas performed.RESULTS: There was a substantial correlation between both readers (CCC = 0.9802-0.9919). Esophageal dilatation was significantlyassociated with SSc (P = .0012). The optimal calculated cut-off value to differentiate SSc from other ILDs was 18.5 mm (sensitivity andspecificity of 70 and 90%, respectively; area under the curve 0.819), measured 1 cm above the diaphragmatic hiatus.CONCLUSION: HRCT may have a discriminative role in the presence of both ILD and esophageal dilatation for the diagnosis of SSc.Our results suggest that a cut-off value for the esophageal diameter of 18.5 mm might propose the diagnosis of SSc with reasonableconfidence

🔖

Bu Makaleye Atıf Yap

FİGUEİREDO, F., COSTA, J. O. F. C., MATOS, A., RAMALHO, M. (2021). Esophageal Dilatation as a Predictor of Systemic Sclerosis in Patients with Interstitial Lung Disease. Turkish Thoracic Journal, Cilt: 22 - Sayı: 3, 231–236. https://ajindex.com/articles/414140

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Santosa A, Tan CS, Teng GG et al. Lung and gastrointestinal complications are leading causes of death in SCORE, a multiethnic Singapore systemic sclerosis cohort. Scand J Rheumatol. 2016
  2. 45(6):499-506. [CrossRef] 2. Elhai M, Meune C, Boubaya M et al. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 2017
  3. 76(11):1897-1905. [CrossRef] 3. Kolstad KD, Li S, Steen V, Chung L, PHAROS Investigators. Long-term outcomes in systemic sclerosis-associated pulmonary arterial hypertension From the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry (PHAROS). Chest. 2018
  4. 154(4):862-871. [CrossRef] 4. Kirby DF, Chatterjee S. Evaluation and management of gastrointestinal manifestations in scleroderma. Curr Opin Rheumatol. 2014
  5. 26(6):621-629. [CrossRef] 5. Crowell MD, Umar SB, Griffing WL, et al. Esophageal motor abnormalities in patients with scleroderma: Heterogeneity, risk factors, and effects on quality of life. Clin Gastroenterol Hepatol. 2017
  6. 15(2):207-213.e1. [CrossRef] 6. Denaxas K, Ladas SD, Karamanolis GP. Evaluation and management of esophageal manifestations in systemic sclerosis. Ann Gastroenterol. 2018
  7. 31(2):165-170. [CrossRef] 7. Christmann RB, Wells AU, Capelozzi VL, Silver RM. Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: Clinical, radiologic, histopathologic, and treatment evidence. Semin Arthritis Rheum. 2010
  8. 40(3):241-249. [CrossRef] 8. Lee JS, Collard HR, Anstrom KJ et al. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: An analysis of data from three randomised controlled trials. Lancet Respir Med. 2013
  9. 1(5):369-376. [CrossRef] 9. Vettori S, Tolone S, Capocotta D et al. Esophageal high-resolution impedance manometry alterations in asymptomatic patients with systemic sclerosis: Prevalence, associations with disease features, and prognostic value. Clin Rheumatol. 2018
  10. 37(5):1239-1247. [CrossRef] 10. Raja J, Ng CT, Sujau I, Chin KF, Sockalingam S. High-resolution oesophageal manometry and 24-hour impedance-pH study in systemic sclerosis patients: Association with clinical features, symptoms and severity. Clin Exp Rheumatol. 2016
  11. 34(5)(suppl 100):115-121. 11. van den Hoogen F, Khanna D, Fransen J et al. Classification criteria for systemic sclerosis: an ACR-EULAR collaborative initiative. Arthritis Rheum. 2013
  12. 65(11):2737-2747. [CrossRef] 12. Salaffi F, Di Carlo M, Carotti M et al. Relationship between interstitial lung disease and oe